Professor Wing Wong Elected to the National Academy of Sciences
SAN DIEGO, May 18 /PRNewswire-AsiaNet/ --
aTyr Pharma Scientific Advisory Board Member Recognized for
Development of
Statistical Methods and Software
Wing Hung Wong, Professor of Statistics and of Health Research &
Policy at Stanford University has been elected to the US National Academy
of Sciences. Election to the National Academy of Sciences is one of the
highest honors that can be accorded to a scientist in the US and this
honor recognizes Professor Wong’s significant contributions in developing
statistical methods and software for analyzing complex databases, such as
those from high throughput genomics research.
With over 100 publications in peer reviewed journals, Professor Wong
has developed ground-breaking methods for turning large data sets into
useful information about biological systems. His contributions to
biological advancements through computational analysis are many, and
include methods and algorithms for the analysis of gene expression data
from microarray chips, identification of gene regulatory elements in
developmental genomics, and elucidation of genetic networks.
According to Professor Paul Schimmel, co-founder of aTyr Pharma and
fellow NAS member: “We are pleased to see this well deserved recognition
of Professor Wong’s valuable contributions to computational analysis of
complex biological data. As a member of our scientific advisory board,
Professor Wong has provided invaluable guidance for building aTyr’s
platform of naturally occurring, therapeutic splice variants of human
tRNA synthetases. His work with genomics data has accelerated
understanding of biology and paved the way for significant health
advances.” aTyr Pharma congratulates Professor Wong on this well
deserved honor.
Company Contact: Media Contact:
Cheryl Quinn Jennifer James
Director of Business Development Alta Partners
aTyr Pharma (415) 362-4022
858-731-8390 jjames@altapartners.com
cquinn@atyrpharma.com
SOURCE: aTyr Pharma
CONTACT: Cheryl Quinn, Director of Business Development of aTyr
Pharma, +1-858-731-8390,
cquinn@atyrpharma.com; or
Jennifer James of Alta Partners,
+1-415-362-4022,
jjames@altapartners.com, for aTyr Pharma
Translations:
NEWS 
